Radiotherapy-induced miR expression influences breast cancer recurrence formation.
收藏官方服务：
资源简介：
Radiotherapy-induced miR expression influences breast cancer recurrence formation.
应用场景：
创建时间：
2017-01-03
相关数据集
Circulating miRNA signature in serum of pateints with primary sclerosing cholangitis (PSC), cholangiocarcinoma (CC) and healthy controls.
RNA was isolated from serum of pateints with PAS, CC and healthy controls. Global microRNA profiling was done using miRNome microRNA Profiler QuantiMir Human PCR Array (#RA660A-1, version 15; BioCat,
NIAID Data Ecosystem20
Table 3_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
BackgroundNeurobrucellosis (NB) is a rare complication of brucellosis that presentis with a variety of clinical symptoms, complicating its diagnosis. This study aimed to analyze the microRNA (miRNA) p
NIAID Data Ecosystem00
Table 7_Analyzing Hedgehog pathway-related genes: insights into breast cancer tumor microenvironment and prognostic implications.xlsx
Study objectivesGiven the significant global burden of breast cancer, this study aims to systematically explore the role of Hedgehog (Hh) pathway-related genes in breast cancer prognosis and immunolog
NIAID Data Ecosystem00
Table2_A comprehensive in silico analysis and experimental validation of miRNAs capable of discriminating between lung adenocarcinoma and squamous cell carcinoma.docx
BackgroundAccurate differentiation between lung adenocarcinoma (AC) and lung squamous cell carcinoma (SCC) is crucial owing to their distinct therapeutic approaches. MicroRNAs (miRNAs) exhibit variabl
NIAID Data Ecosystem00
qPCR panels for plasma microRNAs of responders versus non responders metastatic castration resistant prostate cancer patients to abiraterone acetate. qPCR panels for plasma microRNAs of responders versus non responders metastatic castration resistant prostate cancer patients to abiraterone acetate
Abiraterone acetate (AA) serves as a medication for managing persistent testosterone production in patients with metastatic castration-resistant prostate cancer (mCRPC). However, its efficacy varies a
NIAID Data Ecosystem00
